184 related articles for article (PubMed ID: 2141047)
1. The human C3b receptor: function and role in human diseases.
Tausk F; Gigli I
J Invest Dermatol; 1990 Jun; 94(6 Suppl):141S-145S. PubMed ID: 2141047
[TBL] [Abstract][Full Text] [Related]
2. The expression of C3b receptors in the differentiation of discoid lupus erythematosus and systemic lupus erythematosus.
Tausk F; Harpster E; Gigli I
Arthritis Rheum; 1990 Jun; 33(6):888-92. PubMed ID: 2141982
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.
Wilson JG; Ratnoff WD; Schur PH; Fearon DT
Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021
[TBL] [Abstract][Full Text] [Related]
4. The human C3b receptor.
Cook J; Kazatchkine M
Nouv Rev Fr Hematol (1978); 1983; 25(5):297-301. PubMed ID: 6228780
[TBL] [Abstract][Full Text] [Related]
5. Reduced erythrocyte CR1 (CD 35) receptor function and complement opsonization in factor I-deficient patients is restored by plasma infusion.
Jepsen HH; Teisner B; Rasmussen JM; Svehag SE
Scand J Immunol; 1989 Feb; 29(2):247-55. PubMed ID: 2522236
[TBL] [Abstract][Full Text] [Related]
6. The human C3b receptor (CR1).
Weiss L; Fischer E; Haeffner-Cavaillon N; Jouvin MH; Appay MD; Bariety J; Kazatchkine M
Adv Nephrol Necker Hosp; 1989; 18():249-69. PubMed ID: 2522267
[TBL] [Abstract][Full Text] [Related]
7. Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome.
Tausk FA; McCutchan A; Spechko P; Schreiber RD; Gigli I
J Clin Invest; 1986 Oct; 78(4):977-82. PubMed ID: 2944915
[TBL] [Abstract][Full Text] [Related]
8. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
Roberts WN; Wilson JG; Wong W; Jenkins DE; Fearon DT; Austen KF; Nicholson-Weller A
J Immunol; 1985 Jan; 134(1):512-7. PubMed ID: 2578050
[TBL] [Abstract][Full Text] [Related]
9. Immune complex binding to erythrocyte-CR1 (CD 35), CR1 expression and levels of erythrocyte-fixed C3 fragments in SLE outpatients.
Jepsen HH; Møller Rasmussen J; Teisner B; Schrøder L; Holmskov U; Jarlbaek L; Isager H; Svehag SE
APMIS; 1990 Jul; 98(7):637-44. PubMed ID: 2144431
[TBL] [Abstract][Full Text] [Related]
10. Quantification of the complement receptor function on polymorphonuclear leukocytes: its significance in patients with systemic lupus erythematosus.
Yoshida K; Yukiyama Y; Miyamoto T
J Rheumatol; 1987 Jun; 14(3):490-6. PubMed ID: 3498035
[TBL] [Abstract][Full Text] [Related]
11. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
[TBL] [Abstract][Full Text] [Related]
12. Binding and catabolism of aggregated immunoglobulins containing C3b by U937 cells.
Mehta RL; Takahashi H; Rudick RA; Knutson DW
J Immunol; 1986 Mar; 136(5):1765-71. PubMed ID: 2936811
[TBL] [Abstract][Full Text] [Related]
13. Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE).
Cohen JH; Lutz HU; Pennaforte JL; Bouchard A; Kazatchkine MD
Clin Exp Immunol; 1992 Mar; 87(3):422-8. PubMed ID: 1531948
[TBL] [Abstract][Full Text] [Related]
14. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
15. Human complement receptors for C3b (CR1) and C3d (CR2).
Fearon DT
J Invest Dermatol; 1985 Jul; 85(1 Suppl):53s-57s. PubMed ID: 2989379
[TBL] [Abstract][Full Text] [Related]
16. Glomerular CR1 express in situ cofactor activity for degradation of C3b.
Vedeler CA; Matre R; Iversen BM
Int Arch Allergy Appl Immunol; 1990; 92(1):60-3. PubMed ID: 2147176
[TBL] [Abstract][Full Text] [Related]
17. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
Pascual M; Schifferli JA
Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
[TBL] [Abstract][Full Text] [Related]
18. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
[TBL] [Abstract][Full Text] [Related]
20. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.
Medof ME; Nussenzweig V
J Exp Med; 1984 Jun; 159(6):1669-85. PubMed ID: 6233387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
